SC insulin delivery creates a paradoxical peripheral hyperinsulinemia necessary to achieve minimal insulin concentration in the portal system able to inhibit hepatic glucose production, thus, preventing fasting hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.